Phonak Audéo Lumity vs Signia Pure C&G IX

The Phonak Audéo Lumity is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,398. In HearAdvisor's lab testing, it earned a SoundScore of 4.1/5 (A grade), ranking #21 of 36 prescription hearing aids tested. This device demonstrates clear strengths in specific performance areas. Music streaming quality is strong at 4.1/5, scoring 1.46 points above the category average—a notable advantage for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, meaning the Lumity maintained stability without audible feedback during our standardized challenge tests. Speech in quiet environments also performs solidly at 3.7/5, measuring 0.37 points above the prescription category average. However, the Lumity shows a significant weakness in own-voice comfort, scoring just 1.0/5—a full 1.75 points below the category average. This low score suggests users may notice more occlusion or an unnatural quality to their own voice. Speech in noise performance is mixed at 2.1/5; while this is slightly above the category average (+0.19 points), it remains modest in absolute terms. The Audéo Lumity is best suited for users who prioritize excellent streaming quality and reliable feedback control, and who are less sensitive to own-voice occlusion effects. Those who struggle primarily with speech understanding in noisy environments may want to compare against higher-scoring competitors in this price range, such as the Phonak Sphere Infinio or Oticon Intent.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.